GlaxoSmithKline and the University of Leicester in the U.K. will collaborate to discover and develop novel medicines to treat high-grade non-Hodgkin’s lymphoma. The project is part of GSK’s Discovery Partnerships with Academia initiative. Professor Simon Wagner, from the Department of Cancer Studies, who is leading the project on behalf of the University of Leicester, said:...
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
